老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Control Bionics Ltd
0.060
-0.001
-1.64%
成交量:
2.21萬
成交額:
1,325
市值:
3,258.53萬
市盈率:
-3.06
高:
0.060
開:
0.060
低:
0.060
收:
0.061
52周最高:
0.095
52周最低:
0.032
股本:
5.43億
流通股本:
1.14億
量比:
0.09
換手率:
0.02%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.020
每股收益(LYR):
-0.020
淨資產收益率:
-122.92%
總資產收益率:
-48.20%
市淨率:
5.16
市盈率(LYR):
-3.06
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Control Bionics Ltd——美國市場準入最後障礙掃清,首批收入瞄準2026年9月
美股速递
·
08/27
Control Bionics 完成Neurostrip美國FDA註冊與設備列名
投资观察
·
08/04
Control Bionics:設備交付後預計每年可產生250萬至350萬美元收入
美股速递
·
03/26
Control Bionics披露客户意向:計劃每年採購大量基於iOS的語音生成設備
美股速递
·
03/26
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/CBL.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CBL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","market":"AU","secType":"STK","nameCN":"Control Bionics Ltd","latestPrice":0.06,"timestamp":1789539120000,"preClose":0.061,"halted":0,"volume":22085,"delay":0,"changeRate":-0.016393442622950834,"nameEN":"Control Bionics Ltd","floatShares":114482928,"shares":543088709,"eps":-0.0196,"marketStatus":"未開盤","change":-0.001,"latestTime":"09-16 16:12:00 AEST","open":0.06,"high":0.06,"low":0.06,"amount":1325,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0196,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.061,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.0893316527537162,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CBL.AU","preClose":0.061,"auctionPrice":0.06,"auctionVolume":24579,"auction":3,"marketStatus":"盘后竞价","timestamp":1789539001744}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","floatShares":114482928,"roa":"-48.20%","roe":"-122.92%","lyrEps":-0.0196,"volumeRatio":0.0893316527537162,"shares":543088709,"dividePrice":0,"high":0.06,"amplitude":0,"preClose":0.061,"low":0.06,"week52Low":0.032,"pbRate":"5.16","psRate":"6.84","week52High":0.095,"institutionHeld":0,"latestPrice":0.06,"eps":-0.0196,"divideRate":0,"volume":22085,"delay":0,"ttmEps":-0.0196,"open":0.06,"prevYearClose":0.061,"prevWeekClose":0.061,"prevMonthClose":0.06,"prevQuarterClose":0.074,"fiveDayClose":0.06,"twentyDayClose":0.06,"sixtyDayClose":0.087,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"CBL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787875200000,"name":null,"time":"","dateTimestamp":1787839200000,"actualEps":null},{"market":"AU","date":"2026-02-26","symbol":"CBL.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1772024400000,"reportTimeType":"","actualEps":null},{"market":"AU","date":"2025-09-01","symbol":"CBL.AU","defaultRemindTime":1756684800000,"type":"split","dateTimestamp":1756648800000,"forFactor":982905,"toFactor":1000000,"ratio":0.9829049999999999},{"date":"2025-07-31","symbol":"CBL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753920000000,"name":null,"time":"","dateTimestamp":1753884000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBL.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191648305","title":"Control Bionics Ltd——美國市場準入最後障礙掃清,首批收入瞄準2026年9月","url":"https://stock-news.laohu8.com/highlight/detail?id=1191648305","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191648305?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 06:02","pubTimestamp":1787781729,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd——通往美国市场的最后一道准入关卡已被清除。该公司预计将在2026年9月迎来首批收入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141091983","title":"Control Bionics 完成Neurostrip美國FDA註冊與設備列名","url":"https://stock-news.laohu8.com/highlight/detail?id=1141091983","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141091983?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 06:42","pubTimestamp":1785796948,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd 近日宣布,已成功完成其Neurostrip产品在美国食品药品监督管理局的注册以及设备列名程序。从注册到列名,整个过程严格遵循了美国监管机构的标准,体现出Control Bionics对品质与安全的极高要求。对于投资者而言,这一进展无疑为Control Bionics的价值增长注入了新的动力。市场普遍预期,随着FDA的官方认可,Neurostrip将有望在更广泛的临床场景中得到应用,进而推动公司营收与品牌影响力的双重提升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128703438","title":"Control Bionics:設備交付後預計每年可產生250萬至350萬美元收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1128703438","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128703438?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 05:23","pubTimestamp":1774473792,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd(CBL.AU)宣布,其设备在完成交付后,预计每年将为公司带来250万至350万美元的稳定营收。这一预期收入规模凸显了公司产品在商业化阶段的增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183029885","title":"Control Bionics披露客户意向:計劃每年採購大量基於iOS的語音生成設備","url":"https://stock-news.laohu8.com/highlight/detail?id=1183029885","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183029885?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 05:23","pubTimestamp":1774473791,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd宣布,其一位客户已明确表示,计划每年向公司采购数量可观的基于iOS操作系统的语音生成设备。这一采购意向凸显了市场对该公司创新辅助技术产品的持续需求,也预示着其核心业务在未来可能实现显著增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CBL.AU\",params:#limit:6,delay:true,,,undefined,":[]}}